Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Revenues:    
Sales of health and beauty aid products - net $ 16,595,499 $ 19,813,262
Other income 11,254 16,836
Total Revenues 16,606,753 19,830,098
Costs and Expenses:    
Cost of sales 6,533,340 7,447,776
Selling, general and administrative expenses 7,868,536 7,052,219
Advertising, cooperative and promotional expenses 1,591,227 1,769,748
Research and development 62,989 58,920
Bad debt expense (recovery) 3,860 (9,172)
Interest expense 488,299 505,872
Total Costs and Expenses 16,548,251 16,825,363
Income before provision for income taxes 58,502 3,004,735
Provision for Income Taxes 3,380,268 1,173,554
Net (Loss) Income $ (3,321,766) $ 1,831,181
Net (Loss) Income per Share:    
Basic (usd per share) $ (0.45) $ 0.26
Diluted (usd per share) $ (0.45) $ 0.26
Weighted Average Shares Outstanding:    
Basic (shares) 7,375,314 7,006,684
Diluted (shares) 7,375,314 7,006,684